NECTA 2026

活動詳細資訊:

NECTA brings together stakeholders in oncology drug development to discuss real-world challenges in areas such as early-phase dose selection, unknown targets and tumor-agnostic precision oncology, the wellbeing of clinical coordinators and investigators, and new approaches to clinical trial design, including perspectives from Asia. 

Novotech will participate as a sponsor and will be available to discuss therapeutic strategy and early-phase trial execution across APAC and other global regions. 

Please schedule a meeting via the form on this page.